APVO Quote, Trading Chart, Aptevo Therapeutics Inc.
home / stock / apvo / apvo quote
$ Last:
Change Percent:
$ Open:
$ Previous Close:
$ High:
$ Low:
0 Volume:
01/01/1970 12:00:00 am Last Trade Date Time:
Quotes are delayed by 15 to 20 minutes.
Last Five Trading Days
| Stock Date | Open Price | Close Price | High | Low | Volume |
|---|---|---|---|---|---|
| 2021-02-26 | 31.68 | 32.71 | 33.1197 | 29.38 | 74,270 |
| 2021-02-25 | 33.25 | 31.62 | 33.9 | 28.43 | 197,137 |
| 2021-02-24 | 33.94 | 33.27 | 36.49 | 32.7923 | 45,880 |
| 2021-02-23 | 34.97 | 34.41 | 34.97 | 32.2701 | 50,776 |
| 2021-02-22 | 35.69 | 35.01 | 36.0465 | 34.4383 | 34,007 |
| 2021-02-19 | 37.2 | 36.09 | 37.2 | 35.4168 | 34,811 |
| 2021-02-18 | 39.28 | 36.62 | 39.95 | 35.78 | 80,092 |
| 2021-02-17 | 40.49 | 40.01 | 40.96 | 37.33 | 65,701 |
| 2021-02-16 | 37.01 | 40.59 | 40.91 | 37.01 | 61,781 |
| 2021-02-15 | 36.41 | 37.01 | 37.4 | 35.36 | 50,140 |
| 2021-02-12 | 36.41 | 37.01 | 37.4 | 35.36 | 50,140 |
| 2021-02-11 | 39 | 36.76 | 39.98 | 35.41 | 70,152 |
| 2021-02-10 | 42.2 | 37.69 | 43.21 | 37.69 | 130,994 |
| 2021-02-09 | 34.99 | 38.57 | 38.96 | 34.67 | 99,379 |
| 2021-02-08 | 35.26 | 34.75 | 36 | 34.08 | 32,195 |
| 2021-02-05 | 35.3729 | 35.28 | 35.84 | 34.0109 | 23,383 |
| 2021-02-04 | 35.44 | 34.75 | 35.81 | 34.17 | 30,038 |
| 2021-02-03 | 35.63 | 35.21 | 35.83 | 34.59 | 26,904 |
| 2021-02-02 | 33.97 | 35.09 | 35.78 | 33.66 | 57,307 |
| 2021-02-01 | 34.09 | 33.6 | 34.739 | 32.85 | 35,572 |
Aptevo Therapeutics Inc. Company Name:
APVO Stock Symbol:
NASDAQ Market:
Aptevo Therapeutics Inc. Website:
News, Short Squeeze, Breakout and More Instantly...
-
Stockholders Are Not Required to Take Any Action at this Time SEATTLE, WA / ACCESSWIRE / February 9, 2021 / Aptevo Therapeutics Inc. (NASDAQ:APVO), a clinical-stage biotechnology company focused on developing novel immuno-oncology therapeutics based on its proprietary ADAPTIR™ an...
-
Click here to read the previous top NASDAQ biotech stocks article. It’s been a stellar year for the NASDAQ Biotechnology Index (INDEXNASDAQ: NBI ), which started at 3,763.05 points in January and reached a high of 4,811.03 points on December 15. While the inde...
-
New Bispecific Therapeutic Candidate APVO442 uses ADAPTIR-FLEX Platform Technology APVO442 is a Unique T-Cell Engager Designed to Target PSMA and CD3 for the Treatment of Prostate Cancer SEATTLE, WA / ACCESSWIRE / December 2, 2020 / Aptevo Therapeutics Inc. ("Aptevo" or the "Compan...